Market Cap 348.09M
Revenue (ttm) 92.13M
Net Income (ttm) -18.66M
EPS (ttm) N/A
PE Ratio 62.86
Forward PE 62.30
Profit Margin -20.25%
Debt to Equity Ratio 0.24
Volume 370,200
Avg Vol 402,172
Day's Range N/A - N/A
Shares Out 18.57M
Stochastic %K 13%
Beta 1.25
Analysts Strong Sell
Price Target $17.50

Company Profile

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awa...

Industry: Health Information Services
Sector: Healthcare
Phone: 248 651 6568
Address:
260 Charles Street, Suite 302, Waltham, United States
WrappedLunatic
WrappedLunatic Oct. 7 at 12:41 AM
$OPRX yikes
0 · Reply
LayerOne
LayerOne Oct. 5 at 3:52 PM
$OPRX Healthcare technology. Testing key support. Volume pattern shows distribution. Growth concerns persisting.
0 · Reply
sirspanky
sirspanky Oct. 3 at 7:30 PM
$HCTI 🚀 Bullish quick hits • Platform traction: QuantumNexis on Ezovion has processed $20M$37M projected usage; gateway adds a take-rate lever (recurring fees). • Valuation gap: Trading near micro-cap lows while our base-case math pencils $5$6.5/sh on conservative EV/Sales vs peers. • Runway improved: Recent cash in from warrant exercises extends operations and funds growth. • Multi-region scale: India/KSA/Malaysia expansion + marketplace routes make onboarding easier. • Catalysts ahead: Gateway go-live, new logos, regulatory/commercial updates. Bottom line: execution + multiple expansion is the setup. Watching $3 reclaim next. Peers to watch: $OPRX $HIMS #DigitalHealth #AIinHealthcare
0 · Reply
sirspanky
sirspanky Oct. 2 at 3:06 PM
$HCTI Cliffs after the dip • Why it fell: Warrant inducement = quick cash now (~$1.63M) but near-term dilution. New share count ≈ 6.75M. • Where we stand: At $2.54, implied EV ≈ $9.2M vs $12–14M revenue → only 0.6–0.8× EV/Sales (micro-cap peers often 2.0–3.5×). • Fair value math: Base case ~$6.47/sh (post-deal). Even if all new $3 warrants exercise later, FV still ~$6.10/sh (fully diluted). • Execution tailwinds: QuantumNexis/Ezovion $20M processed → $37M guide; payment gateway adds a take-rate monetization lever. • Watch next: 8-K terms, gateway go-live, regional wins (India/KSA/MY), new logos. Bottom line: The deal stung, but cash runway improved and valuation is well below conservative comps. If execution continues, multiple expansion is the story. $HCTI $OPRX $HIMS (Not financial advice.)
0 · Reply
sirspanky
sirspanky Oct. 2 at 2:10 PM
$HCTI 🚀 QuantumNexis Milestone on Ezovion EMR: $20M processed in usage-based revenue, guiding to $37M in coming months + integrated payment gateway on deck. This is real platform throughput + a clear path to monetize volume (take-rate) across India, Bangladesh, KSA, Malaysia. Why it matters: • Proof of adoption → recurring, higher-margin potential • Fintech rails = new revenue lever (fees) • Expansion across multiple regions = durability, not one-off If execution continues, multiple expansion becomes the story. Watching for gateway rollout, new logos, and marketplace wins. Peers to watch: $RCM $OPRX $HIMS
0 · Reply
MaverikIT
MaverikIT Sep. 29 at 9:21 PM
$OPRX +1.12
0 · Reply
wellsmccormick
wellsmccormick Sep. 18 at 2:11 PM
$OPRX This is not tech theater. NXXT delivers uptime that clinics and towns bank on. Expect PRs highlighting saves and contracts locking multiyear revenue.
0 · Reply
Doozio
Doozio Sep. 5 at 10:11 AM
EXTReme $OPRT unties with no huckleberries still in $OPRX during 🐒🍌🧠⏰♾️
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 8:45 PM
$OPRX Excellent article that nails exactly where OPRX stands right now. So if you want to update your OPRX knowledge or get acquainted with OPRX, this is a must read. https://beyondspx.com/quote/OPRX/optimizerx-leveraging-integrated-tech-and-data-for-profitable-growth-nasdaq-oprx#analysis
0 · Reply
Aldebaran_Intelligence
Aldebaran_Intelligence Sep. 4 at 10:00 AM
$APPS Check out another firm $OPRX which used Blue Torch lending back in 2023. (up 300% since Dec'24)
0 · Reply
Latest News on OPRX
OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:26 PM EDT - 2 months ago

OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript


OptimizeRx: Stock Could Rise As Profitability Is Achieved

Jul 18, 2025, 3:47 PM EDT - 2 months ago

OptimizeRx: Stock Could Rise As Profitability Is Achieved


OptimizeRx to Participate in Upcoming Investor Conferences

May 16, 2025, 7:30 AM EDT - 5 months ago

OptimizeRx to Participate in Upcoming Investor Conferences


OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript

May 12, 2025, 9:56 PM EDT - 5 months ago

OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript


OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 11:04 AM EDT - 7 months ago

OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript


OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 10:58 PM EST - 11 months ago

OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript


OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript

May 14, 2024, 11:21 PM EDT - 1 year ago

OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript


OptimizeRx Reports First Quarter 2024 Financial Results

May 14, 2024, 4:01 PM EDT - 1 year ago

OptimizeRx Reports First Quarter 2024 Financial Results


OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 11:20 AM EDT - 1 year ago

OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript


OptimizeRx Corporation (OPRX) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 11:48 AM EST - 2 years ago

OptimizeRx Corporation (OPRX) Q3 2023 Earnings Call Transcript


OptimizeRx Reports Third Quarter 2023 Financial Results

Nov 6, 2023, 7:00 AM EST - 2 years ago

OptimizeRx Reports Third Quarter 2023 Financial Results


OptimizeRx Expands AI Powered Omnichannel Platform

Aug 24, 2023, 8:00 AM EDT - 2 years ago

OptimizeRx Expands AI Powered Omnichannel Platform


OptimizeRx Corporation (OPRX) Q2 2023 Earnings Call Transcript

Aug 14, 2023, 6:54 PM EDT - 2 years ago

OptimizeRx Corporation (OPRX) Q2 2023 Earnings Call Transcript


WrappedLunatic
WrappedLunatic Oct. 7 at 12:41 AM
$OPRX yikes
0 · Reply
LayerOne
LayerOne Oct. 5 at 3:52 PM
$OPRX Healthcare technology. Testing key support. Volume pattern shows distribution. Growth concerns persisting.
0 · Reply
sirspanky
sirspanky Oct. 3 at 7:30 PM
$HCTI 🚀 Bullish quick hits • Platform traction: QuantumNexis on Ezovion has processed $20M$37M projected usage; gateway adds a take-rate lever (recurring fees). • Valuation gap: Trading near micro-cap lows while our base-case math pencils $5$6.5/sh on conservative EV/Sales vs peers. • Runway improved: Recent cash in from warrant exercises extends operations and funds growth. • Multi-region scale: India/KSA/Malaysia expansion + marketplace routes make onboarding easier. • Catalysts ahead: Gateway go-live, new logos, regulatory/commercial updates. Bottom line: execution + multiple expansion is the setup. Watching $3 reclaim next. Peers to watch: $OPRX $HIMS #DigitalHealth #AIinHealthcare
0 · Reply
sirspanky
sirspanky Oct. 2 at 3:06 PM
$HCTI Cliffs after the dip • Why it fell: Warrant inducement = quick cash now (~$1.63M) but near-term dilution. New share count ≈ 6.75M. • Where we stand: At $2.54, implied EV ≈ $9.2M vs $12–14M revenue → only 0.6–0.8× EV/Sales (micro-cap peers often 2.0–3.5×). • Fair value math: Base case ~$6.47/sh (post-deal). Even if all new $3 warrants exercise later, FV still ~$6.10/sh (fully diluted). • Execution tailwinds: QuantumNexis/Ezovion $20M processed → $37M guide; payment gateway adds a take-rate monetization lever. • Watch next: 8-K terms, gateway go-live, regional wins (India/KSA/MY), new logos. Bottom line: The deal stung, but cash runway improved and valuation is well below conservative comps. If execution continues, multiple expansion is the story. $HCTI $OPRX $HIMS (Not financial advice.)
0 · Reply
sirspanky
sirspanky Oct. 2 at 2:10 PM
$HCTI 🚀 QuantumNexis Milestone on Ezovion EMR: $20M processed in usage-based revenue, guiding to $37M in coming months + integrated payment gateway on deck. This is real platform throughput + a clear path to monetize volume (take-rate) across India, Bangladesh, KSA, Malaysia. Why it matters: • Proof of adoption → recurring, higher-margin potential • Fintech rails = new revenue lever (fees) • Expansion across multiple regions = durability, not one-off If execution continues, multiple expansion becomes the story. Watching for gateway rollout, new logos, and marketplace wins. Peers to watch: $RCM $OPRX $HIMS
0 · Reply
MaverikIT
MaverikIT Sep. 29 at 9:21 PM
$OPRX +1.12
0 · Reply
wellsmccormick
wellsmccormick Sep. 18 at 2:11 PM
$OPRX This is not tech theater. NXXT delivers uptime that clinics and towns bank on. Expect PRs highlighting saves and contracts locking multiyear revenue.
0 · Reply
Doozio
Doozio Sep. 5 at 10:11 AM
EXTReme $OPRT unties with no huckleberries still in $OPRX during 🐒🍌🧠⏰♾️
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 8:45 PM
$OPRX Excellent article that nails exactly where OPRX stands right now. So if you want to update your OPRX knowledge or get acquainted with OPRX, this is a must read. https://beyondspx.com/quote/OPRX/optimizerx-leveraging-integrated-tech-and-data-for-profitable-growth-nasdaq-oprx#analysis
0 · Reply
Aldebaran_Intelligence
Aldebaran_Intelligence Sep. 4 at 10:00 AM
$APPS Check out another firm $OPRX which used Blue Torch lending back in 2023. (up 300% since Dec'24)
0 · Reply
ZacksResearch
ZacksResearch Sep. 3 at 2:36 PM
🚀 Top Zacks Growth Picks for Sept 3: • $OPRX$PHIN$KT All just hit Zacks Rank #1 (Strong Buy)—a clean roundup of high-conviction growth plays for the week ahead. https://www.zacks.com/commentary/2745852/new-strong-buy-stocks-for-september-3rd?art_rec=home-home-top_stories-ID01-txt-2745852+&cid=sm-stocktwits-1-2745852-oc-10722&ADID=SYND_STOCKTWITS_TWEET_1_2745852_OC_10722
0 · Reply
indievestments
indievestments Aug. 26 at 10:18 PM
$OPRX remember looking at this 10 years ago. Now a 4 banger off the lows. Last qtr big growth +55% and looks to become Rule of 40 co. On watch now.
0 · Reply
MuesLee
MuesLee Aug. 14 at 9:00 PM
$KULR $OPRX right decision so far
0 · Reply
DarthGoat
DarthGoat Aug. 14 at 7:52 PM
$OPRX OOOUUTTTTT +15%
0 · Reply
MuesLee
MuesLee Aug. 14 at 3:28 PM
$OPRX closed at 17.26 to open $KULR before ER at 5.14
0 · Reply
MaverikIT
MaverikIT Aug. 13 at 9:48 PM
@howardlindzon $OPRX - only 1.1K follower$
0 · Reply
StockScanners
StockScanners Aug. 13 at 3:51 AM
$OPRX reached 18.22
0 · Reply
Doozio
Doozio Aug. 12 at 9:36 PM
Fook OPRA she is ILMNati bahhht $OPRX Appears $EXTR emly 🧠. 🐒🍌🧠⏰♾️
0 · Reply
garygb
garygb Aug. 11 at 6:47 PM
$OPRX Yes.
0 · Reply
MuesLee
MuesLee Aug. 11 at 2:35 PM
$OPRX reopened at 16.05. I expect that train to leave soon to new levels.
0 · Reply
DarthGoat
DarthGoat Aug. 11 at 2:01 PM
$OPRX IIIIIIINNNNNN
1 · Reply
JarvisFlow
JarvisFlow Aug. 11 at 12:30 PM
JMP Securities has adjusted their stance on OptimizeRx ( $OPRX ), setting the rating to Market Outperform with a target price of 14 → 20.
0 · Reply